Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipopolysaccharide lipid A is the highly conserved, hydrophobic anchor of the lipopolysaccharide (LPS) molecule, embedded within the outer leaflet of the Gram-negative bacterial outer membrane (Raetz & Whitfield, 2002). It is widely recognized as the 'endotoxin' component of the bacterial cell wall, responsible for the potent inflammatory response triggered during Gram-negative infections (Park et al., 2009). Lipid A is essential for bacterial viability and serves as a critical permeability barrier, protecting the cell from toxic substances. This essentiality makes it a primary target for cationic antimicrobial peptides such as polymyxin B and colistin, which bind to the lipid A phosphate groups to disrupt membrane integrity (Velkov et al., 2013). In the host, lipid A is detected by the Toll-like receptor 4 (TLR4)/MD-2 complex, which initiates a signaling cascade leading to the production of pro-inflammatory cytokines (Opal, 2010). While this immune activation is vital for controlling infection, excessive or systemic release of lipid A can lead to life-threatening conditions such as sepsis and septic shock (Opal et al., 2013). Consequently, lipid A is a major focus for both the development of novel antibiotics and the creation of anti-sepsis therapies designed to neutralize its toxic effects.
Polymyxin antibiotics bind to the lipid A moiety of lipopolysaccharide, displacing stabilizing divalent cations and causing disruption of the bacterial outer membrane, which leads to increased permeability and cell death (Velkov et al., 2013).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide lipid A (Lipid A) (Lipid A).